Ambarella Inc vs Smith & Nephew plc — how do they compare? Ambarella Inc trades at $83.82 (market cap $3.64B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 3.4× Ambarella Inc's market cap, and Smith & Nephew plc pays a 2.65% dividend while Ambarella Inc pays none. Which is the better fit depends on your goals.
| AMBA | SNN | |
|---|---|---|
Market Cap | $3.64B | $12.54B |
Sector | Technology | Health |
52-Week High | $95.51 | $38.70 |
52-Week Low | $48.65 | $28.73 |
Enterprise Value | $3.37B | $15.57B |
Dividend Yield | — | 2.65% |
Trailing returns across standard periods
Ambarella is a semiconductor company specializing in low-power video compression and computer vision processors. Its chips power AI cameras for security, automotive safety, and robotics applications.
Read more on AMBA →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →